Injectable Drug Delivery Market Poised to Reach USD 1,034.78 Billion by 2030
The global healthcare landscape is rapidly shifting toward patient-centric treatment models, creating unprecedented demand for advanced injectable drug delivery solutions. According to MarketsandMarkets, the Injectable Drug Delivery Market is projected to grow from USD 690.23 billion in 2025 to USD 1,034.78 billion by 2030, registering a CAGR of 8.4% during the forecast period. The market’s expansion is fueled by the increasing burden of chronic diseases, rising adoption of biologics, technological innovations in self-administration devices, and growing demand for home healthcare. Injectable therapies have become the preferred choice for delivering biologics, vaccines, insulin, oncology drugs, and many specialty medicines due to their high bioavailability, rapid therapeutic action, and ability to preserve drug stability. As pharmaceutical innovation continues to evolve, injectable drug delivery systems are becoming more convenient, safer, and patient-friendly than ever before....